Specificity
Highly expressed in brain and adrenal gland with moderate expression in liver, lung, spleen, prostate and spinal cord. Low expression in heart, uterus and prostate. Undetectable in blood cells. In the brain, strongly expressed in cortical regions, substan
Tag/Conjugate
Unconjugated
SequenceSimilarities
Belongs to the FAD-binding oxidoreductase/transferase type 4 family.Contains 1 FAD-binding PCMH-type domain.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. Information available upon request.
Antigen Description
This gene encodes a flavin adenine dinucleotide (FAD)-dependent oxidoreductase which catalyzes the reduction of the delta-24 double bond of sterol intermediates during cholesterol biosynthesis. The protein contains a leader sequence that directs it to the endoplasmic reticulum membrane. Missense mutations in this gene have been associated with desmosterolosis. Also, reduced expression of the gene occurs in the temporal cortex of Alzheimer disease patients and overexpression has been observed in adrenal gland cancer cells. [provided by RefSeq, Jul 2008]
Function
UDP-N-acetylmuramate dehydrogenase activity; delta24-sterol reductase activity; enzyme binding; flavin adenine dinucleotide binding; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; peptide antigen binding;
Synonyms
DHCR24; 24-dehydrocholesterol reductase; DCE; SELADIN1; Nbla03646; seladin-1; delta(24)-sterol reductase; seladin 1; diminuto/dwarf1 homolog; selective AD indicator 1; desmosterol-to-cholesterol enzyme; 3 beta-hydroxysterol delta 24-reductase; 3-beta-hydroxysterol delta-24-reductase;
Citations
Publication ()
Have you cited DAG-P1961 in a publication?
Let us know and earn a reward for your research.